New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- New NJACTS Publication
- Scientists Discover Immune Cell Networks Driving Deadly Lung Disease.
- Special Type of Fat Tissue Could Help Maintain Exercise Capacity in Aging.
- Fruit Fly Research Led NJIT Scientists and Edison Teens to Better AI Habits on Supercomputers.
- Biologist Pabitra Sahoo and His Research Team Unlock Clues to Repairing Damaged Nerves.
Categories
- Community (2,190)
- Covid (983)
- CTO Events (6)
- News (2,797)
- Pilots (21)